Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dalhoff

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Arzneimittel-Forschung|January 1, 1981
[Studies on the pharmacokinetics of amoxicillin after intravenous, intramuscular and oral administration (author's transl)]A Dalhoff, P Koeppe, D von Kobyletzki
Infection|March 7, 2006
Kinetics and quantification of antibacterial effects of beta-lactams, macrolides, and quinolones against gram-positive and gram-negative RTI pathogensK-J Schaper, S Schubert, A Dalhoff
Chemotherapy|January 1, 1986
Penetration of ciprofloxacin into gynecological tissues following oral and intravenous administrationE Goormans, A Dalhoff, B Kazzaz, et al.
Infection|November 1, 1986
Penetration of ciprofloxacin into human lung tissue following intravenous injectionD Schlenkhoff, A Dalhoff, J Knopf, et al.
Infection|July 25, 2009
A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpointsA Dalhoff, P G Ambrose, J W Mouton
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2001
Penicillin-resistant streptococcus pneumoniae: review of moxifloxacin activityA Dalhoff, C Krasemann, S Wegener, et al.
Chemotherapy|January 1, 1985
Ciprofloxacin distribution in prostatic tissue and fluid following oral administrationJ B Boerema, A Dalhoff, F M Debruyne
Antimicrobial Agents and Chemotherapy|August 4, 1998
Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjectsH Stass, A Dalhoff, D Kubitza, et al.
Lancet (London, England)|September 22, 1984
Intraprostatic concentrations of ciprofloxacin after intravenous administrationJ B Boerema, F M Debruyne, A Dalhoff
European Journal of Clinical Microbiology|April 1, 1986
Single and multiple dose pharmacokinetics of ciprofloxacinU Ullmann, W Giebel, A Dalhoff, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Arzneimittel-Forschung|January 1, 1981
[Studies on the pharmacokinetics of amoxicillin after intravenous, intramuscular and oral administration (author's transl)]A Dalhoff, P Koeppe, D von Kobyletzki
Infection|March 7, 2006
Kinetics and quantification of antibacterial effects of beta-lactams, macrolides, and quinolones against gram-positive and gram-negative RTI pathogensK-J Schaper, S Schubert, A Dalhoff
Chemotherapy|January 1, 1986
Penetration of ciprofloxacin into gynecological tissues following oral and intravenous administrationE Goormans, A Dalhoff, B Kazzaz, et al.
Infection|November 1, 1986
Penetration of ciprofloxacin into human lung tissue following intravenous injectionD Schlenkhoff, A Dalhoff, J Knopf, et al.
Infection|July 25, 2009
A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpointsA Dalhoff, P G Ambrose, J W Mouton
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2001
Penicillin-resistant streptococcus pneumoniae: review of moxifloxacin activityA Dalhoff, C Krasemann, S Wegener, et al.
Chemotherapy|January 1, 1985
Ciprofloxacin distribution in prostatic tissue and fluid following oral administrationJ B Boerema, A Dalhoff, F M Debruyne
Antimicrobial Agents and Chemotherapy|August 4, 1998
Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjectsH Stass, A Dalhoff, D Kubitza, et al.
Lancet (London, England)|September 22, 1984
Intraprostatic concentrations of ciprofloxacin after intravenous administrationJ B Boerema, F M Debruyne, A Dalhoff
European Journal of Clinical Microbiology|April 1, 1986
Single and multiple dose pharmacokinetics of ciprofloxacinU Ullmann, W Giebel, A Dalhoff, et al.
Pageof 11